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Introduction: Immunoglobulin G4-related disease (IgG4-RD) is a newly recognized fibro-inflammatory condition.
Forty-two cases with immunoglobulin G4-related sialadenitis (IgG4-RS) confirmed by histopathological and immu-
nohistochemical assessment were studied to clarify the clinicopathologic characteristics of the salivary glands in-
volved in IgG4-RS, especially the relationship between the histopathologic features and function of salivary glands
or serum levels of IgG4.
Methods: Clinical, serologic, imaging and histopathological data of these cases were analyzed. CT volumes of
submandibular, parotid, and lacrimal glands were calculated. The saliva flow rate was measured. Scintigraphy with
99mTc-pertechnetate was undertaken in 31 cases, and the concentration index (CI) and secretion index (SI) was cal-
culated. Relationships between fibrosis severity and salivary gland function or serum IgG4 levels were analyzed.
Results: The first symptom was swelling of bilateral submandibular or lacrimal glands. Physical examination showed
multiple bilateral major salivary glands (including sublingual and accessory parotid glands) and lacrimal glands were
enlarged in IgG4 RS. Multiple enlarged cervical lymph nodes were noted in 30 patients. Saliva flow at rest was
lower than normal in 34 cases; stimulated saliva flow was lower than normal in 15 cases. Secretory function was
reduced more severely in the submandibular glands than in the parotid glands. Serum levels of IgG4 were elevated
in 95.2% of cases and 78.6% patients had increased IgE levels. Serum IgG4 level was higher and saliva secretion
lower as glandular fibrosis increased.
Conclusions: Prominent changes in the morphology, histology, immunohistochemistry and secretion of the major
salivary glands of IgG4-RS patients were accompanied by involvement of the lacrimal glands and cervical lymph
nodes. Elevated IgE, allergic history, eosinophil infiltration suggest allergic reactions as a potential pathogenesis of
IgG4-RS. Severity of glandular fibrosis correlated with salivary function and serum levels of IgG4.Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a newly
recognized fibroinflammatory condition. The disease is
characterized by tumefactive lesions, a dense lymphoplas-
macytic infiltrate rich in IgG4-positive plasma cells, stori-
form fibrosis, and often (but not always) elevated serum
concentrations of IgG4 in organs [1]. IgG4-RD was not* Correspondence: gaoyan0988@163.com; gyyu@263.net
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creativecommons.org/publicdomain/zero/1.0/recognized as a systemic disease until 2003, when extra-
pancreatic manifestations were identified in patients with
autoimmune pancreatitis (AIP) [2].
IgG4-RD has been described in virtually every organ
system: the biliary tree, salivary glands, periorbital tissues,
kidneys, lungs, lymph nodes, meninges, aorta, breast,
prostate gland, thyroid gland, pericardium, and skin [2–6].
Symptoms vary depending on the affected organs. Some
patients may experience severe complications, such as ob-
struction or compression symptoms due to organomegaly
or hypertrophy, as well as organ dysfunction caused by
cellular infiltration or fibrosis [7].
Identification of IgG4-positive plasma cells in Küttner
tumors and Mikulicz disease propelled renewed interest indistributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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of inflamed salivary glands [8–10]. Considerable evidence
supports the concept of IgG4-related sialadenitis (IgG4-
RS), a category that subsumes Küttner tumors and
Mikulicz disease.
Since IgG4-RS has been established as an entity in this
century, clinicopathologic studies have been carried out
in different countries [8, 9, 11, 12]. The disease seems to
be found worldwide. However, the clinicopathologic
features of IgG4-RS are not well characterized. A few
studies on functional changes compared with the histo-
pathologic features of the involved salivary gland have
been reported [13]. Finding sufficient histopathologic in-
formation on IgG4-RS for pathologic grading is difficult
owing to a lack of biopsy materials.
The present study was carried out to obtain more clin-
icopathologic information about IgG4-RS. In particular,
we wished to clarify the characteristics of the salivary
gland(s) involved in IgG4-RS. The relationship between
the histopathologic features and function of salivary glands,
the serum level of IgG4, and the number of IgG4-positive
cells were analyzed to judge disease severity.
Methods
The study protocol was approved by the Ethical Com-
mittee for Human Experiments of the Peking University
School of Stomatology (Beijing, China) and was con-
ducted in accordance with the Declaration of Helsinki
guidelines for human research. All patients provided in-
formed consent prior to participation in this study.
Forty-two patients were referred to the Department of
Oral and Maxillofacial Surgery at Peking University
School of Stomatology between August 2011 and June
2014. The patients were selected for this study because of
bilateral swelling of submandibular glands with or without
swelling of multiple exocrine glands (lacrimal, parotid,
and sublingual glands) of >3 months duration. The diag-
nosis was made on the basis of symptoms, serologic ana-
lyses, imaging, and histopathological findings [14]. Clinical
data (age, sex, anatomic site, duration of swelling, imaging,
and physical examination) were recorded.
Measurement of the volume of major salivary glands and
lacrimal glands
Computed tomography (CT) was carried out with an
eight-slice scanner (BrightSpeed; GE Medical Systems,
Piscataway, NJ, USA). Volumes of the lacrimal, parotid,
and submandibular glands were reconstructed by volume
rendering [15, 16] and compared with normal values that
we provided previously [17]. The diagnosis of glandular
enlargement was made if their volumes were larger than
normal values. The accessory parotid glands are only pea-
sized upon CT imaging. Enlargement of the accessory par-
otid glands was judged if CT showed a volume obviouslylarger than 1 cm in diameter. Judgment of enlargement of
the sublingual glands was by physical examination because
of the difficulty in measurement by imaging. CT images
were assessed by an experienced radiologist and a maxillo-
facial surgeon (Z-PS and WL).
Measurement of salivary secretion
Whole saliva was collected as described previously [18,
19]. Five minutes after collection of whole saliva at rest,
stimulated whole saliva using 2.5 % citric acid solution
was collected for another 5 minutes. The saliva flow rate
was calculated using the following formula:
Saliva flow rate ¼ ðweightof tubewithcollectedsaliva–
weightof empty tubeÞ:
Scintigraphy
Scintigraphy with 99mTc-pertechnetate was undertaken
in 31 cases using a standardized protocol [20]. The con-
centration index (CI) was calculated using the following
formula:
CI ¼ maximumuptakevalue–backgroundð Þ= background:
The period from stimulation using 2.5 % citric acid so-
lution to the minimum value after stimulation within 30
minutes was considered to be the “secretion phase”. The
secretion index (SI) was calculated using the following
formula:
SI ¼ ðmaximumvaluebefore stimulationusingcitric acid–
minimumvalueafter stimulationusingcitricacidÞ=
ðmaximumvaluebefore stimulationusingcitric acid–
backgroundÞ  100 %:
Mean values of bilateral sides were taken to be the
CI and SI of the parotid and submandibular glands,
respectively.
Serologic examinations
Serologic analyses were undertaken for antinuclear anti-
body (ANA), IgE, IgA, IgM, total IgG, and subclasses of
IgG using the Array 360 Immunoassay Assay Protein
Serology Chemistry Analyzer system (Beckman Coulter,
Fullerton, CA, USA) by rate nephelometry immunoassay
after generating charts and logs from quality control ma-
terials and the quality control. Anti-SS-A and anti-SS-B
antibodies were tested by western blotting.
Histological examination
All 42 cases underwent histopathologic examination.
Hematoxylin and eosin-stained slides of all cases were
reviewed by two pathologists (YC and YG) independently
according to the diagnostic criteria for IgG4-RS [7, 14].
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of eosinophils were quantified (HPF area = 0.2375 mm2).
The severity of inflammation and fibrosis was divided
into three stages according to Seifert’s classification with
slight modification [21]. The first stage proposed by
Seifert was abandoned because focal chronic inflamma-
tion with nests of lymphocytic infiltrates was not suffi-
cient to diagnose IgG4-RS by pathologic means.
Stage 1 referred to marked diffuse lymphoplasmacytic
infiltration. Lymphoid follicles had developed. Fibrosis in
the centers of lobules or periductal areas as well as atro-
phy of acini were noted (Fig. 1a). Stage 2 referred to even
more prominent lymphoplasmacytic infiltration: forma-
tion of lymphoid follicles with expanded reactive germinal
centers, reduction of the parenchyma of secretory glands,
myofibroblast hyperplasia, and storiform fibrosis. One
could observe severe fibrosis in the centers of lobules or
periductal areas as well as severe atrophy of acini, but the
outlines of the lobules remained (Fig. 1b). Stage 3 referred
to destruction of the lobular architecture with marked
parenchymal loss and sclerosis: the outlines of lobules
were not clear. Germinal centers degenerated and light
areas were obscured (Fig. 1c).
Immunohistochemical examination
Tissue sections (thickness 4 μm) were deparaffinized and
rehydrated. Endogenous peroxidase activity was blocked
using 3 % H2O2. For antibodies against human IgG4
(Epitomics, Burlingame, CA, USA), IgG (Epitomics), and
CD21 (Zhongshan, Beijing, China), antigen retrieval was
achieved by treating sections with a boiling citric acid
buffer solution (0.01 mol/l, pH 6.0) for 10 minutes in a
microwave oven. Color was developed in freshly made di-
aminobenzidine. Sections were washed briefly in runningFig. 1 The inflammation and fibrosis grade of IgG4-RS. a Stage 1: marked d
developed. Fibrosis in the centers of lobules or periductal areas and atroph
prominent lymphoplasmacytic infiltration, with formation of lymphoid follic
the salivary gland, myofibroblast hyperplasia, and storiform fibrosis. Severe
of acini, but the outline of lobules is retained (H&E, ×100). c Stage 3: destru
sclerosis, the outlines of lobules are not clear. Germinal centers have degen
and eosintap water and stained lightly with Mayer’s hematoxylin.
Negative controls were obtained by omission of the rele-
vant primary antibody.
Three identical HPFs with the greatest density of IgG-
positive and IgG4-positive plasma cells were quantified.
The ratio of IgG4-positive plasma cells to IgG-positive
plasma cells was calculated for each patient.
Statistical analyses
Statistical analyses were performed using SPSS version
13.0 (SPSS, Chicago, IL, USA). Categorical variables were
compared using the chi-square or Fisher exact test. Con-
tinuous variables are the mean ± standard deviation, and
compared by the independent t test or the Wilcoxon rank
sum test. P <0.05 was considered significant.
Results
Of the 42 patients who comprised the study cohort, 16
were males and 26 were females with a ratio of 1:1.625.
The median age was 55 (range 23–89) years.
Case history
The first sign that patients found was bilateral swelling
of the submandibular glands (12/42, 28.6 %) or the lacri-
mal glands (14/42, 33.3 %), followed by swelling of the
unilateral submandibular gland (5/42, 11.9 %), bilateral
parotid gland (5/42, 11.9 %), and bilateral sublingual
gland (1/42, 2.4 %). The interval between swelling of the
first gland and swelling of the second gland was 1–96
(mean 22.6) months. Four (9.5 %) patients had AIP, six
(14.3 %) cases had asthma, six (14.3 %) subjects had
interstitial pneumonia, 22 (52.4 %) cases had rhinosinu-
sitis, and two (4.8 %) cases had dysaudia.iffuse lymphoplasmacytic infiltration. Lymphoid follicles have
y of acini (H&E staining, ×100 magnification). b Stage 2: even more
les with reactive germinal centers, reduction of the parenchyma in
fibrosis in lobule centers or periductal areas as well as severe atrophy
ction of the lobular architecture with marked parenchymal loss and
erated and the light area is obscured (H&E, ×100). H&E hematoxylin
Fig. 3 Enlargement of the lacrimal (arrowheads) and submandibular
glands (arrows)
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Physical examinations revealed that 64 of the total 69
submandibular glands (15 submandibular glands were
resected before physical examination) were enlarged in
27 bilateral cases and 10 unilateral cases. Twenty-two out
of 83 parotid glands (one parotid gland was resected be-
fore physical examination) were enlarged in nine bilateral
cases and four unilateral cases. Fifty-five lacrimal glands
were enlarged in 27 bilateral cases and one unilateral case.
Bilateral enlargement of sublingual glands was observed in
22 patients (Fig. 2). Bilateral enlargement of the accessory
parotid glands was noted in eight patients. Enlargement of
at least two major salivary glands or lacrimal glands was
found in 35/42 (83.3 %) patients (Fig. 3). Multiple enlarged
cervical lymph nodes were observed in 30 patients.
Upon milking the submandibular or parotid glands, a
reduced amount of clear saliva flowed out of the ductal
orifice in 26 patients. No obvious saliva could be milked
from the submandibular gland in 15 (35.7 %) cases or
from the parotid gland in five patients. The oral mucosa
was wet with preservation of the saliva pool at the
mouth floor in 28 patients. Mild dryness of the oral mu-
cosa was found in seven (16.7 %) cases but the saliva
pool had disappeared in 14 (33.3 %) cases. Rampant car-
ies was not observed.
CT volumes of submandibular, parotid, and lacrimal glands
Forty-one patients underwent CT examination. CT vol-
umes of the enlarged submandibular, parotid and lacri-
mal glands are presented in Table 1. Compared with the
normal reference of glandular volumes, 67 out of 69
submandibular glands (13 submandibular glands were
resected before CT examination) were enlarged in 30 bi-
lateral cases and seven unilateral cases. Fifty-three out of
81 parotid glands (one parotid gland was resected before
CT examination) were enlarged in 24 bilateral cases and
five unilateral cases. Fifty-nine out of 79 lacrimal glandsFig. 2 Enlargement of the sublingual glands (arrows)(one lacrimal gland was resected before CT examination
and one patient did not undergo CT examination of the
lacrimal glands) were shown to be enlarged in 27 bilateral
cases and five unilateral cases. Bilateral enlargement of the
accessory parotid glands was found in 9/41 (22.0 %) cases
(Fig. 4).
Flow rate of whole saliva and scintigraphy
The saliva flow rate at rest was 0.07–4.88 (mean 1.02 ±
0.94) g/5 minutes. Flow rates were lower than the nor-
mal value (1.9 g/5 minutes) in 34 (81.0 %) cases. The
stimulated saliva flow rate was 2.06–17.34 (mean 8.76 ±
4.10) g/5 minutes, and nine (35.7 %) cases showed a
lower stimulated saliva flow rate than the normal value
(6.75 g/5 minutes) [22].
Thirty-one cases underwent 99mTc-pertechnetate scin-
tigraphy to evaluate the uptake and secretory function of
submandibular and parotid glands. The mean CI of the
submandibular glands was lower than normal value in
22.6 % patients, whereas the mean CI of the parotid
glands was normal for all patients. The mean SI of the
submandibular glands was lower than the normal value
in 77.4 % patients, whereas the mean SI of the parotid
glands was lower than the normal value in 45.2 % of
subjects. Secretory function was reduced more severely
in the submandibular glands than in the parotid glands.
Table 1 Quantitative measurements of the volumes of enlarged glands in IgG4-related sialadenitis and normal controls
Age
(years)
Parotid gland Submandibular gland Lacrimal gland





























































































Data presented as mean ± standard deviation (cm3)













Fig. 4 Bilateral enlargement of the accessory parotid glands (short
arrows) and main parotid glands (long arrows) are observed on
CT film
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In the 39 cases in whom the percentage of eosinophils
in peripheral blood was measured, eight (20.5 %) cases
showed elevated levels (7.7–14.1 %). The level of IgG
was elevated in 53.8 % of patients. The level of IgG4 was
elevated in 95.2 % of subjects. A total of 28.6 % of sub-
jects had an elevated level of IgG2, and 78.6 % of pa-
tients had an increased level of IgE. The reaction to
anti-SSA, anti-SSB, and anti-ANA was negative in all pa-
tients except for one patient who had a positive reaction
to anti-SSA.
Histopathological and immunohistochemical examinations
Gross views revealed the involved glands to be enlarged
and firm but their configurations to be maintained. The
cut surface varied in different areas. In the most serious
areas, gland tissue was homogeneous and appeared as
an ill-defined mass. The color was white or pale yellow.
Upon more careful study, the structure of glandular lob-
ules could be ascertained. Uninvolved areas retained the
appearance of a normal gland.
Histological sections revealed preservation of the lobu-
lar architecture, marked lymphoplasmacytic inflamma-
tion, large irregular lymphoid follicles with expanded
germinal centers, and acinar atrophy without prominent
lymphoepithelial lesions. Characteristically, prominent
cellular interlobular fibrosis was shown to be due to
activated fibroblasts, and infiltration of lymphocytes and
plasma cells was shown. Plasma cells were mature with-
out sign of atypia. Eosinophil infiltration in the involved
areas was noted in 20 cases (47.6 %), and the number
ranged from 2/HPF to 98/HPF (median 16/HPF). Oblit-
erative phlebitis was noted in 30 cases.
According to our modified Seifert classification, out of
42 cases 14 patients were classified as stage-1 disease,
stage-2 disease, and stage-3 disease, respectively.Numbers of IgG4-positive-stained plasma cells were
increased in all cases. Mean numbers of IgG-positive
and IgG4-positive plasma cells per HPF were 167 ± 42
(range 79–246) and 124 ± 42 (range 56–215), respect-
ively. The IgG4/IgG ratio was 73.7 ± 12.8 % (range
50.4–93.9 %).
Relationship between histopathological changes and
clinical features
Clinical features, serologic and immunohistochemical ex-
aminations, and secretion function of the salivary glands of
patients with stage-1, stage-2 and stage-3 diseases are sum-
marized in Table 2. Serum levels of IgG and IgG4 as well
as the numbers of IgG-positive and IgG4-positive cells in-
creased, whereas the ratio of (IgG1 + IgG3) / (IgG2 +
IgG4) decreased significantly (P <0.05) as glandular fibrosis
became more severe. Also, the stimulated flow rate and
CI of the submandibular gland decreased significantly
(P <0.05) as glandular fibrosis became more severe.
Discussion
IgG4-RD is accepted as an immune-mediated disease
involving multiple disorders such as sclerosing pancrea-
titis, sclerosing cholangitis, tubulointerstitial nephritis,
interstitial pneumonia, retroperitoneal fibrosis, inflam-
matory pseudotumor of the liver and lung, inflammatory
aortic aneurysms, and enlargement of the salivary and
lacrimal glands [2, 23–25]. IgG4-RS is a component of
IgG4-RD, and the main presentation is enlargement of
the salivary and lacrimal glands.
Histopathological studies based on biopsy material in-
volving IgG4-RS in the major salivary glands are few. Most
histopathological information is derived from whole-gland
ectomy specimens. We believe it is important to take bi-
opsies from the involved major salivary gland (especially
the submandibular glands) to make a definite diagnosis of
IgG4-RS for two main reasons. First, a relatively large dose
of glucocorticoids (“assault therapy”) in the short term
and a small dose as maintenance therapy in the long term
are typical first-line therapies [1]. The results are excellent,
but the side effects can limit use of these regimens. Such
treatments should therefore be given only to patients with
a definitive diagnosis of IgG4-RS. Second, an elevated
serum level of IgG4 is found not only in IgG4-RD, but also
in Churg–Strauss syndrome, multicentric Castleman dis-
ease, and eosinophilic disorders as well as in some patients
with rheumatoid arthritis, systemic sclerosis, chronic
hepatitis, and liver cirrhosis [26, 27]. Sah and Chari [27]
found that approximately 30 % of patients had a normal
serum IgG4 level despite typical histopathological and
immunohistochemical findings of IgG4-RD. In the present
series, two cases had a normal serum level of IgG4 despite
also possessing the typical clinicopathologic features of
IgG4-RS. In contrast, the histopathological and
Table 2 Relationship between different parameters and histopathologic grade
Histopathologic grade
I II III P
(n = 14) (n = 14) (n = 14)
Clinical features
Male/female 3: 4 3: 11 1:1
Age (years) 54.1 52.0 57.4 0.539
Volumes of swollen salivary glands PG 39.65 ± 8.15 38.68 ± 10.9 34.56 ± 6.03 0.223
SMG 14.52 ± 2.00 16.31 ± 3.40 16.23 ± 2.64 0.068
Serologic examinations
IgG (mg/dl) 15776.4 ± 6304.9 15838.0 ± 3993.0 26226.7 ± 9820.8 0.001
IgG2 (mg/dl) 539.6 ± 225.3 510.8 ± 195.2 531.7 ± 221.8 0.935
IgG4 (mg/dl) 647.8 ± 700.1 818.6 ± 894.1 1802.8 ± 1011.0 0.002
T-IgE (KU/U) 626.4 ± 705.5 361.9 ± 401.8 372.2 ± 344.2 0.433
EOS (%) 4.7 ± 3.3 3.6 ± 3.4 4.8 ± 3.6 0.638
(IgG1 + IgG3) / (IgG2 + IgG4) (%) 88.3 ± 48.7 70.6 ± 23.0 47.2 ± 17.5 0.007
Immunohistochemical examinations IgG4+ (cells/HPF) 90 ± 27 134 ± 33 143 ± 43 0.001
IgG+ (cells/HPF) 133 ± 37 172 ± 37 191 ± 42 0.001
IgG4+/IgG+ (%) 68.7 ± 12.2 78.0 ± 9.8 74.0 ± 13.2 0.125
EOS (cells/HPF) 23 ± 22 17 ± 7 11 ± 7 0.097
Flow rate of whole saliva Rest (g/5 minutes) 1.04 ± 0.72 1.04 ± 1.27 0.82 ± 0.51 0.757
Stimulated (g/5 minutes) 10.11 ± 3.23 8.12 ± 4.24 6.78 ± 2.57 0.045
Scintigraphy CI (%) PG 74.22 ± 9.12 77.02 ± 10.77 67.26 ± 11.00 0.094
SMG 53.29 ± 12.54 49.05 ± 9.10 34.20 ± 9.26 <0.001
SI (%) PG 47.33 ± 15.10 52.14 ± 10.15 46.90 ± 14.50 0.603
SMG 38.50 ± 17.50 27.12 ± 9.70 26.1 ± 8.50 0.055
CI concentration index, EOS eosinophil, HPF high power field, PG parotid gland, SI secretion index, SMG submandibular gland, T-IgE total immunoglobulin E
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nostic criteria of IgG4-RS even though the serum level of
IgG4 was elevated in two cases (who were excluded from
our study). Histopathological and immunohistochemical
analyses of biopsy specimens therefore remain the corner-
stone for the diagnosis of IgG4-RS.
The relatively superficial location of the submandibu-
lar glands enables incisional biopsy, which is difficult for
affected internal organs such as the pancreas and kid-
neys. The biopsy was undertaken under local anesthesia.
The superficial part of the glands was chosen for biopsy.
Gland tissue of dimension 0.7 cm × 0.5 cm was excised
for biopsy. The wound in the glands was closed care-
fully. No complications were found and secretory func-
tion was not affected.
Usually, IgG4-RS involves swelling of multiple exocrine
glands (including lacrimal, parotid, and submandibular
glands). This was true of our series. Gland volume was
measured by CT volume rendering and was compared
with normal values. Compared with the results ofpalpation, the number of enlarged parotid glands in-
creased obviously according to the measurement of gland
volume by CT. Twenty-two out of 83 parotid glands were
enlarged in nine bilateral cases and four unilateral cases
according to physical examination. Fifty-three of 81 (one
patient did not undergo CT examination) parotid glands
were enlarged in 24 bilateral cases and five unilateral cases
according to measurement of the gland volume by CT.
The main reason for these discrepancies between the two
methods of measurement is that the anatomy of the par-
otid glands is irregular and difficult for accurate evaluation
by palpation if the swelling is not obvious, whereas CT
volume rendering can detect enlargement of the parotid
glands accurately and quantitatively. The high prevalence
of enlargement of the parotid glands in IgG4-RS should
be noted, and CT volume rendering is advocated. Bilateral
enlargement of the sublingual glands and accessory par-
otid glands is very rare in other diseases but is relatively
common in IgG4-RS. In the present study, unexpected
bilateral swelling of the sublingual glands (52.4 %) and
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swelling of the sublingual glands and/or accessory parotid
glands is therefore an important clinical feature in the
diagnosis of IgG4-RS.
We agree with Geyer and Deshpande [28] that unilat-
eral and solitary gland involvement should also be ac-
cepted within the spectrum of IgG4-RS. In the present
study, the mean interval between the first swelling of
glands and subsequent swelling of glands was 22.6
months. Cases involving a unilateral gland could be
followed by involvement of more glands if treatment is
not given.
As a component of IgG4-related systemic disease,
careful monitoring of the pancreas, gallbladder, kid-
neys, and lungs should be undertaken to identify other
systemic diseases in the diagnosis of IgG4-RS. The
nose, paranasal sinuses, and ears are also involved very
often along with the salivary and lacrimal glands in
IgG4-RS. A total of 71.4 % cases in the present study
had lymphadenopathy of the upper cervical lymph
nodes. Swelling of the cervical lymph nodes was the
first symptom and sign in three cases. Lymphadenop-
athy of the cervical lymph nodes should therefore also
be considered an important clinical feature in the diag-
nosis of IgG4-RS.
Saliva flow rates and scintigraphy with 99mTc-pertech-
netate are effective for evaluation of the function of the
major salivary glands. These procedures are relatively
easy to carry out, noninvasive, and well tolerated. Stud-
ies have shown that IgG4-RS leads to a mild reduction
in saliva flow [29]. In the present study, most cases
showed a mild or moderate reduction in the saliva flow
rate. The saliva flow rate at rest was lower than the
normal value in 81.0 % of cases and the stimulated flow
rate was lower than the normal value in 35.7 % of sub-
jects. 99mTc-pertechnetate scintigraphy showed that the
percentage of patients with a mean SI lower than the
normal value was higher in the submandibular glands
(77.4 %) than in the parotid glands (45.2 %), suggesting
that damage to the submandibular glands was more se-
vere than that to the parotid glands in IgG4-RS.
There is evidence of autoimmune disorder in AIP but
there are also signs of an allergic nature in its pathogen-
esis. In our series, an elevated serum level of IgG4 was
detected in 95.2 % of cases along with an obviously ele-
vated level of IgE in 78.6 %. In one study of 42 patients
with AIP, the IgG4 level was elevated in 93 % of cases
and the IgE level was elevated in 86 % of cases [30].
High levels of IgE have also been detected in IgG4-
related lymphadenopathy and IgG4-related kidney dis-
ease [31]. In the present study, 20.5 % of patients had an
increased percentage of eosinophils in peripheral blood.
Histological evaluation revealed eosinophil infiltration
in inflamed glands in 47.6 % of cases. Asthma wasobserved in 14.3 % of IgG4-RS cases. These results sug-
gest a possible allergic origin of IgG4-RS.
Elevated IgE levels and eosinophil infiltration are among
the criteria for the diagnosis of IgG4-RD [14]. Serum con-
centrations of IgG4 and IgE have been shown to be signifi-
cantly higher in IgG4-RD than in Sjögren syndrome [24].
However, few studies on IgG4-RS have focused on serum
concentrations of IgE and eosinophil infiltration [32, 33].
We propose that elevated serum levels of IgE, history of al-
lergic diseases, and eosinophil infiltration should be taken
into consideration in the diagnosis of IgG4-RS.
Seifert [21] put forward a histopathologic grading
standard for chronic sclerosing sialadenitis. That classifi-
cation was based on inflammation of the salivary glands
(including some local factors that induced salivary in-
flammation) without the prominent characteristics of
autoimmune systemic disease. Ectopic germinal centers
and fibroblasts are the main causes of the development
and progression of autoimmune inflammation [34–36].
To accord with the histopathologic characteristics of
IgG4-RS, the Seifert classification was modified into three
grades on the basis of germinal centers and fibrosis in our
study. This grading system can reflect the severity of fibro-
sis in the salivary glands.
As the severity of glandular fibrosis increased, serum
levels of IgG and IgG4 in the three classes increased
significantly, whereas the (IgG1 + IgG3) / (IgG2 + IgG4)
ratio decreased significantly. These data suggest that the
results of serological examinations have a good correlation
with histopathologic grading, thereby enabling serological
results to be used to estimate lesion severity.
The stimulated flow rate of whole saliva decreased
with increasing histopathological grade. Increased fi-
brosis was accompanied by a decreased CI in scinti-
grams in the submandibular glands, suggesting that the
increase in inflammatory fibrosis and glandular func-
tion had declined. Treatment of IgG4-RS should there-
fore be initiated as early as possible once the definitive
diagnosis is established to preserve the function of in-
volved salivary glands.Conclusions
Biopsy is very important to provide the necessary infor-
mation for the definitive diagnosis of IgG4-RS. Bilateral
swelling of the sublingual glands and accessory parotid
glands, lymphadenopathy of the cervical lymph nodes,
and bilateral enlargement of parotid and submandibular
glands are important clinical features of IgG4-RS. Elevated
serum levels of IgE, allergic history, and eosinophil infil-
tration suggest allergic reactions as a potential pathogen-
esis. Increased fibrosis accompanied with lower salivary
function suggests that the early diagnosis and treatment of
IgG4-RS is very important.
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